The impact of the introduction of fidaxomicin on the management of Clostridium difficile infection in seven NHS secondary care hospitals in England: a series of local service evaluations

Clostridium difficileRibotype 027: Relationship to Age, Detectability of Toxins A or B in Stool With Rapid Testing, Severe Infection, and Mortality

(2015) Krishna Rao et al.   CLINICAL INFECTIOUS DISEASES

Recurrent Clostridium difficile infection is associated with increased mortality

(2015) M.A. Olsen et al.   CLINICAL MICROBIOLOGY AND INFECTION

Risk Factors for Recurrent Clostridium difficile Infection: A Systematic Review and Meta-Analysis

(2015) Abhishek Deshpande et al.   INFECTION CONTROL AND HOSPITAL EPIDEMIOLOGY

Highlighting clinical needs in Clostridium difficile infection: the views of European healthcare professionals at the front line

(2015) J.M. Aguado et al.   JOURNAL OF HOSPITAL INFECTION

Clostridium difficile Recurrence Is a Strong Predictor of 30-Day Rehospitalization Among Patients in Intensive Care

(2014) Marya D. Zilberberg et al.   INFECTION CONTROL AND HOSPITAL EPIDEMIOLOGY

Excess length of stay and mortality due to Clostridium difficile infection: a multi-state modelling approach

(2014) E. van Kleef et al.   JOURNAL OF HOSPITAL INFECTION

Risk Factors for Recurrence, Complications and Mortality in Clostridium difficile Infection: A Systematic Review

(2014) Claire Nour Abou Chakra et al.   PLoS One

Fidaxomicin versus vancomycin for infection with Clostridium difficile in Europe, Canada, and the USA: a double-blind, non-inferiority, randomised controlled trial

(2012) Oliver A Cornely et al.   LANCET INFECTIOUS DISEASES

The effect of hospital-acquired infection with Clostridium difficile on length of stay in hospital

(2011) A. J. Forster et al.   CANADIAN MEDICAL ASSOCIATION JOURNAL

Frequent Hospital Readmissions for Clostridium difficile Infection and the Impact on Estimates of Hospital-Associated C. difficile Burden

(2011) Courtney R. Murphy et al.   INFECTION CONTROL AND HOSPITAL EPIDEMIOLOGY

Fidaxomicin versus Vancomycin forClostridium difficileInfection

(2011) Thomas J. Louie et al.   NEW ENGLAND JOURNAL OF MEDICINE

European Society of Clinical Microbiology and Infectious Diseases (ESCMID): treatment guidance document for Clostridium difficile infection (CDI)

(2009) M.P. Bauer et al.   CLINICAL MICROBIOLOGY AND INFECTION

Recurrent Clostridium difficile infection: causality and therapeutic approaches

(2009) Stuart Johnson   INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS

Delayed transfer of care from NHS secondary care to primary care in England: its determinants, effect on hospital bed days, prevalence of acute medical conditions and deaths during delay, in older adults aged 65 years and over

(2009) Krishantha H Jasinarachchi et al.   BMC Geriatrics

Clostridium difficile— More Difficult Than Ever

(2008) Ciarán P. Kelly et al.   NEW ENGLAND JOURNAL OF MEDICINE